This phase II/III trial compares the addition of radiation therapy to the usual treatment (immunotherapy with or without chemotherapy [carboplatin, pemetrexed, paclitaxel, nab-paclitaxel]) versus (vs.) usual treatment alone in treating patients with non-small cell ...
- Carcinoma
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Adenocarcinoma
- Adenocarcinoma of Lung
- Carcinoma, Adenosquamous
Age: 18 years - 66+
Gender: All